Table 1.
Parameter | PL-ASA | EC-ASA | Ratio (%) | 95% CI | p-value |
---|---|---|---|---|---|
AUC0-t (h*ng/mL)a | 601 (41.1) | 416 (53.7) | 144 | 117–178 | 0.0013 |
Cmax (ng/mL)a | 720 (33.7) | 368 (80.3) | 196 | 148–259 | < 0.0001 |
Tmax (h)b | 1.01 (0.47, 3.03) | 4.00 (1.50, 6.63) | < 0.0001 |
The AUC0-t and Cmax analyses were performed on log-transformed parameters using a linear mixed-effects ANOVA model with treatment, period, and sequence as fixed effects and subject as a random effect
AUC0-t area under curve from time zero to last measurable concentration, Cmax maximum concentration, CI confidence interval, h hour, PK pharmacokinetic
aGeometric least square mean (coefficient of variation, %)
bMedian (range)